News Focus
News Focus
icon url

boston745

07/30/19 9:54 PM

#25751 RE: madg #25750

Make believe group thats mentioned on Sonnys ortho companies website, developing products for Sintx hes been working on since 2006 long before he became CEO, and Zimmer clearly paid a 2.5m milestone payment Q2 2017 the quarter before Sonny loaned the identical amount to Sintx (July 2017) after completion of a milestone Q1'17.

Also helps sonnys been on Zimmers surgeon panel since 2002 and theres nothing to indicate this relationship terminated in 2014 when he took on the job as CEO.

icon url

boston745

07/31/19 12:02 AM

#25752 RE: madg #25750

The group that does the actual development is the one that gets the milestone payments. Sonnys research team is simply using Sintx and Zimmer IP. The use of third-party developers when companies are direct competitors is very common however:

At the extreme, Katz (1986) notes that if spillovers are perfect and equal (implying that firms are direct product market competitors) then firms may simply choose to contract out the R&D to a third party, and split the costs evenly. The outsourced R&D mechanism works best when product market rivalry is high because it short circuits the outcome where firms all shirk in equilibrium.



Obviously any arrangement with Sintx requires a less than even split. This is evidenced by Global Dental companies paying for the R&D costs and none of the funds show up on Sintx financials.

A licensing contract typically contains an
up-front payment,
milestone payments at successful completion of a project phase,
and royalties on sales.



Licencing contract would exist between Sonny's Research Team and Sintx/Arthroplasty Partner. Since Zimmer paid a milestone payment in 2017 and its IP is involved its likely the Arthroplasty partner.

I have a materials science research program at the Missouri Science & Technology University in Rolla, MO. My colleague, Prof. Rahaman and I have worked with bioactive ceramic technology, training and preparing many graduate PhD students from around the world. With our colleagues from Kyoto, Japan, we are developing super-tough silicon nitride ceramics for hip and knee replacement



Clearly the program exists outside Sintx and is working with Pezzotti s team developing super-tough Si3N4 specifically for Hips/Knees. This program has to get funded somehow.